BridgeBio Pharma, Inc. (BBIO)
78.15
+0.96
(+1.24%)
USD |
NASDAQ |
Jan 21, 16:00
78.01
-0.14
(-0.18%)
After-Hours: 20:00
BridgeBio Pharma Market Cap: 15.06B for Jan. 21, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Pfizer Inc. | 147.20B |
| Alnylam Pharmaceuticals, Inc. | 48.28B |
| Supernus Pharmaceuticals, Inc. | 2.839B |
| Ionis Pharmaceuticals, Inc. | 12.87B |
| Sarepta Therapeutics, Inc. | 2.239B |
Market Cap Related Metrics
| PS Ratio | 42.08 |
| PEG Ratio | -0.2537 |
| Price | 78.15 |
| Earnings Yield | -5.36% |
| PEGY Ratio | -0.2537 |